Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q2 2017 · 10-Q
Revenue$969.00K$969.00K−13.9% vs Q2 2016 Net Income-$6.05M-$6.05MN/M vs Q2 2016 EPS Diluted-$1.94-$1.94N/M vs Q2 2016 Gross Profit$262,000−51.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,028,000N/M Free Cash Flowderived-$5,118,000N/M Margins · derivedGross margin27.0%−21.0 pt vs Q2 2016
Operating margin-576.0%−23.2 pt vs Q2 2016
Net margin-624.3%−55.4 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 11, 2017 · 42 d after period end